US Edition
Perfuze’s Millipede88 Studied for Acute Ischemic Stroke in MARRS Trial - Endovascular Today
Summary by Endovascular Today
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Perfuze’s Millipede88 Studied for Acute Ischemic Stroke in MARRS Trial - Endovascular Today
July 22, 2025—Perfuze, an Ireland-based developer of catheters for interventional stroke care, recently announced preliminary results from the United States pivotal trial of the Millipede 088 superbore aspiration catheter (Millipede88). The findings were presented at SNIS 2025, the Society of NeuroInterventional Surgery’s annual meeting. According to the company, MARRS is evaluating the safety and effectiveness of the Millipede88 system for reva…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
